Life Sciences partner Sophie McGrath and associate Kesten Laverty explain that women’s health and wellness industry has expanded exponentially over the last few years. Read the Maddyness UK article here.
Related Content
- InsightNovember 1, 2024
Four Steps to Maximize the Value of AI Innovation in Medtech
- InsightNovember 1, 2024
How the EU AI Act Could Affect Medtech Innovation
- Big Molecule WatchOctober 31, 2024
Alvotech and Teva Announce FDA Approval of Additional Presentation for Ustekinumab Biosimilar
- Big Molecule WatchOctober 30, 2024
Bio-Thera and Gedeon Richter Reach Exclusive Commercialization Agreement for Ustekinumab Biosimilar
- AlertOctober 25, 2024
NYDFS Publishes Guidance on AI-Related Cybersecurity Risks
- Big Molecule WatchOctober 24, 2024
Accord Biopharma Announces FDA Approval of IMULDOSA (ustekinumab-srlf)
- Big Molecule WatchOctober 23, 2024
Federal Circuit Denies Injunction Pending Appeal After Amgen Beat Preliminary Injunction for Biosimilar Aflibercept
- Big Molecule WatchOctober 23, 2024
GlaxoSmithKline and Northwestern Sue Moderna for Patent Infringement in Trio of Lawsuits
- Speaking EngagementsNovember 12, 2024
US & EP Data Exclusivity: Same Name, Different Games
- Press ReleaseNovember 1, 2024
Goodwin Advises ProQR on $69.8 Million Underwritten Public Offering Closing and $12.3 Million Concurrent Private Placement
- Press ReleaseOctober 31, 2024
Aerovate Therapeutics to Combine with Jade Biosciences in All-Stock Transaction
- Press ReleaseOctober 30, 2024
Goodwin Advises Septerna in $288 Million Upsized Initial Public Offering
- Awards and RankingsOctober 30, 2024
Eight Goodwin Partners Named 2025 IAM Global Leaders
- Press ReleaseOctober 28, 2024
Goodwin Advises TELA on $46 Million Underwritten Public Offering of Common Stock
- Press Release28 October 2024
Myricx Raises £90 Million Series A
- Press ReleaseOctober 22, 2024
Joshua Zachariah Named a Law360 MVP in Mergers & Acquisitions